{"id":7874,"date":"2023-02-24T15:09:56","date_gmt":"2023-02-24T20:09:56","guid":{"rendered":"https:\/\/vaccines.phila.gov\/?post_type=lsvr_notice&p=7874"},"modified":"2024-09-11T15:51:28","modified_gmt":"2024-09-11T19:51:28","slug":"new-vaccine-products-available-through-vfc-2","status":"publish","type":"post","link":"https:\/\/vaccines.phila.gov\/index.php\/new-vaccine-products-available-through-vfc-2\/","title":{"rendered":"New Vaccine Products Available Through VFC"},"content":{"rendered":"

New Vaccine Products Available Through VFC<\/h2>\n

On November 4, 2022, FDA licensed a new formulation of Rotavirus Vaccine, Live, Oral (Rotarix, GSK). The new formulation comes as a liquid that does not require mixing or dilution.\u00a0The new formulation (1.5mL x 10 applicators) will be available for VFC providers to order March 1, 2023.<\/strong>\u00a0The original formulation (1mL x 10 vials and applicators) will be available until the supply is depleted or expires.

To change the formulation that your site orders, complete the Vaccine Change Request Form<\/a>. Our team will review your request and reply with next steps. We recommend that sites that are part of a system or are affiliated use the same vaccine presentations across sites to ensure continuity of care and help prevent administration errors.<\/p>\n

Rotarix<\/strong>
Rotarix, oral (1.5 mL x 10 applicators) will be available March 1, 2023, through the Vaccines Children (VFC) program.<\/div>\n